CDIOW — Cardio Diagnostics Holdings, Inc.

CDIOWCardio Diagnostics Holdings, Inc.

NAS · US · Health Care · Biotechnology · cdio.ai

0.0252USD0.00%Mkt Cap: —P/E: —Last update: 2026-05-22

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assess…

Industry Peers

Biotechnology

Alnylam Pharmaceuticals, Inc.

loading…

Indicators:|

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)14.82K USD

Gross Profit14.82K USD

Net Income (TTM)-6.50M USD

Revenue/Share0.0080 USD

Last Price0.0252 USD

Fiscal Year End—

MR Quarter—

Employees15

CountryUS

SectorHealth Care

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.00

EPS (TTM)—

EPS (Forward)—

52W Range

0.02520% of range0.0341

52W High0.0341 USD

52W Low0.0252 USD

Profitability

Gross Margin100.00%

Oper. Margin-41159.55%

EBITDA Margin0.00%

Profit Margin-43832.49%

ROE-93.19%

ROA-83.67%

Growth

Revenue Growth-21.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.73M USD

CapEx (TTM)419.31K USD

FCF Margin-25698.10%

FCF Yield—

Net Debt-4.42M USD

Net Debt/EBITDA0.73

Balance Sheet

Debt/Equity0.10

Current Ratio9.79

Quick Ratio8.46

Book Value/Sh3.819 USD

Cash/Share1.727 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float2.83M

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta2.26

S&P 52W Chg28.31%

Avg Vol (30d)0

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—